Stage IA Patients With Pancreatic Ductal Adenocarcinoma Cannot Benefit From Chemotherapy: A Propensity Score Matching Study

Purpose: Adjuvant chemotherapy following resection is recommended by clinical practice guidelines for all patients with pancreatic ductal adenocarcinoma (PDAC). This study aimed to evaluate the efficacy of adjuvant chemotherapy among the staging groups of the American Joint Committee on Cancer (AJCC...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yuchao, Xu, Gang, Chen, Maozhen, Wei, Qian, Zhou, Tengteng, Chen, Ziliang, Shen, Mingyang, Wang, Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379031/
https://www.ncbi.nlm.nih.gov/pubmed/32766130
http://dx.doi.org/10.3389/fonc.2020.01018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379031/
https://www.ncbi.nlm.nih.gov/pubmed/32766130
http://dx.doi.org/10.3389/fonc.2020.01018

Ejemplares similares